-
Medical futurist names three trends shaping the future of pharma
London, UK, 8 February 2023 / Sciad Newswire / Empowered patients, robots and artificial intelligence are reshaping the pharmaceutical supply chain, says Dr Bertalan Meskó, Director of The Medical Futurist Institute. He will share insights on the trends influencing the future of the pharmaceutical industry at a free webinar for industry leaders on 22 February…
-
KAUST startup Lihytech raises $6 million to extract lithium from seawater
Thuwal, Saudi Arabia, 2nd February 2023 / Sciad Newswire / Saudi Arabian mining company, Ma’aden, and King Abdullah University of Science and Technology (KAUST) Innovation Ventures fund invest $6 million USD collectively into Lithium Infinity (Lihytech), a startup who have developed an economically feasible way to extract lithium from seawater. With accelerated adoption of electric vehicles (EVs) worldwide…
-
How to create an effective science video – the 5 key components
One of the biggest ways of sharing content right now is through video – it’s the number one source of information for 66% of people*. And when it comes to science, the trend is no different. Creating high quality video content to share your research with a wider audience is invaluable in a world where…
-
Our guide to GA4 – new features, getting started, and useful tips & tricks
If you’re involved in digital marketing or use digital marketing channels to promote your business, you’ll probably have heard about GA4. After 17 years, Google is sunsetting Universal Analytics this July, and replacing it with GA4 – a new platform built in response to changing industry and privacy landscapes. With a fast-evolving digital landscape, and…
-
Watson-Marlow to create biodiverse native woodland in Ireland
Falmouth, United Kingdom, 15th December 2022 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) has announced that it will be supporting the planting of native forests in Southwest Ireland. As trees native to Ireland (such as oak, birch, rowan and alder) tend to grow for hundreds of years, this project will create a long-term biodiverse habitat. The first…
-
NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture
New evidence demonstrates that NoriZite creates a physical barrier to prevent viral infection. Birmingham, UK, 15th December 2022 / Sciad Newswire / Birmingham Biotech LTD, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces new evidence from the University of Birmingham that shows NoriZite™ Nasal Spray can block the infection of the…
-
BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis
Taipei, Taiwan, 8th December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885) is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis (NK), a rare degenerative eye disease which causes very severe cornea damage and can lead to loss…
-
MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease
London, United Kingdom, 6th December 2022 / Sciad Newswire / MultiOmic Health, an artificial intelligence-enabled precision medicine discovery company, today announces the signing of a research collaboration agreement with Northern Care Alliance (NCA) NHS Foundation Trust in Manchester, England. MultiOmic will deploy its MOHSAIC® platform on de-identified bio-samples and clinical histories previously collected by NCA to investigate patient stratifying biomarkers…
-
Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022
London, United Kingdom, 5th December 2022 / Sciad Newswire / With the UK’s health system under pressure, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event. With nurses voting to strike, cancer waiting lists at an all-time high, and a cost-of-living crisis, the NHS…
-
BRIM Biotechnology, Inc. raises $20 million in Series E funding round
Taipei, Taiwan, 1st December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E funding round. This demonstrates the heightened interest and growing demand for new treatments for Dry…